Guo Z - Search Results

1

Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer.

Wang X, Guo Z, Wu X, Chen D, Wang F, Yang L, Luo M, Wu S, Yang C, Huang L, Fu L. Wang X, et al. Among authors: guo z. Immunotargets Ther. 2023 Jan 4;12:1-16. doi: 10.2147/ITT.S373866. eCollection 2023. Immunotargets Ther. 2023. PMID: 36632330 Free PMC article.

2

GM-CSF mediates immune evasion via upregulation of PD-L1 expression in extranodal natural killer/T cell lymphoma.

Rong QX, Wang F, Guo ZX, Hu Y, An SN, Luo M, Zhang H, Wu SC, Huang HQ, Fu LW. Rong QX, et al. Mol Cancer. 2021 May 29;20(1):80. doi: 10.1186/s12943-021-01374-y. Mol Cancer. 2021. PMID: 34051805 Free PMC article.

3

KRAS mutation: from undruggable to druggable in cancer.

Huang L, Guo Z, Wang F, Fu L. Huang L, et al. Among authors: guo z. Signal Transduct Target Ther. 2021 Nov 15;6(1):386. doi: 10.1038/s41392-021-00780-4. Signal Transduct Target Ther. 2021. PMID: 34776511 Free PMC article. Review.

4

Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo.

Fan Y, Tao T, Guo Z, Wah To KK, Chen D, Wu S, Yang C, Li J, Luo M, Wang F, Fu L. Fan Y, et al. Among authors: guo z. Mol Ther Oncolytics. 2022 Feb 16;24:636-649. doi: 10.1016/j.omto.2022.02.006. eCollection 2022 Mar 17. Mol Ther Oncolytics. 2022. PMID: 35284628 Free PMC article.

5

Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo.

Zhang Y, Li C, Xia C, Wah To KK, Guo Z, Ren C, Wen L, Wang F, Fu L, Liao N. Zhang Y, et al. Among authors: guo z. Cell Commun Signal. 2022 Sep 14;20(1):142. doi: 10.1186/s12964-022-00955-8. Cell Commun Signal. 2022. PMID: 36104708 Free PMC article.

6

A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection.

Xiao CZ, Wei W, Guo ZX, Li SH, Zhang YF, Wang JH, Shi M, Guo RP. Xiao CZ, et al. Oncol Lett. 2015 Nov;10(5):2787-2794. doi: 10.3892/ol.2015.3677. Epub 2015 Sep 3. Oncol Lett. 2015. PMID: 26722243 Free PMC article.

7

Risk factors of extra-hepatic progression after transarterial chemoembolization for hepatocellular carcinoma patients: a retrospective study in 654 cases.

Li S, Wang Q, Mei J, Wang J, Zhong XP, Ling Y, Guo Z, Lu LH, Wei W, Guo R. Li S, et al. Among authors: guo r, guo z. J Cancer. 2019 Aug 27;10(20):5007-5014. doi: 10.7150/jca.35355. eCollection 2019. J Cancer. 2019. PMID: 31598173 Free PMC article.

8

Development of prognostic index based on autophagy-related genes analysis in breast cancer.

Lin QG, Liu W, Mo YZ, Han J, Guo ZX, Zheng W, Wang JW, Zou XB, Li AH, Han F. Lin QG, et al. Aging (Albany NY). 2020 Jan 22;12(2):1366-1376. doi: 10.18632/aging.102687. Epub 2020 Jan 22. Aging (Albany NY). 2020. PMID: 31967976 Free PMC article.

9

Risk model and risk stratification to preoperatively predict central lymph node metastasis in papillary thyroid carcinoma.

Luo X, Wang J, Xu M, Zou X, Lin Q, Zheng W, Guo Z, Li A, Han F. Luo X, et al. Among authors: guo z. Gland Surg. 2020 Apr;9(2):300-310. doi: 10.21037/gs.2020.03.02. Gland Surg. 2020. PMID: 32420254 Free PMC article.

10

The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early-stage hepatocellular carcinoma.

Chen ZY, Guo ZX, Lu LH, Mei J, Lin WP, Li SH, Wei W, Guo RP. Chen ZY, et al. Cancer Med. 2021 Aug;10(16):5466-5474. doi: 10.1002/cam4.4102. Epub 2021 Jul 1. Cancer Med. 2021. PMID: 34212527 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,137 results

Search Page

Filters